Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Cell Reports|January 5, 2022
AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemiaAdrien Grenier, Laury Poulain, Johanna Mondesir, et al.
International Journal of Molecular Sciences|February 25, 2023
Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged TissuesStéphanie Solier, Michele Mondini, Lydia Meziani, et al.
Blood|September 10, 2013
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaLise Willems, Nathalie Jacque, Arnaud Jacquel, et al.
Blood Advances|March 8, 2021
Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severityJohan Courjon, Océane Dufies, Alexandre Robert, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 20, 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001Christopher Montemagno, Arnaud Jacquel, Charlotte Pandiani, et al.
Blood|November 14, 2022
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1Lorric Delage, Mireille Lambert, Émilie Bardel, et al.
Nature Medicine|February 14, 2017
The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemiaNina Fenouille, Christopher F Bassil, Issam Ben-Sahra, et al.
The Journal of Investigative Dermatology|December 21, 2018
Caspase 1/11 Deficiency or Pharmacological Inhibition Mitigates Psoriasis-Like Phenotype in MiceLazaro Emilio Aira, Diogo Gonçalves, Jozef P Bossowski, et al.
Cancer Research|June 8, 2021
Dual Covalent Inhibition of PKM and IMPDH Targets Metabolism in Cutaneous Metastatic MelanomaMarwa Zerhouni, Anthony R Martin, Nathan Furstoss, et al.
Pageof 14